1/27/2026CTTQ's TQA3605 Shows Promising Phase 2 Results in Chronic HBV Treatmen...

1/26/2026Visen's Lonapegsomatropin Approved in China for Pediatric GHD

1/26/2026Huahui Wins Conditional Approval in China for First Hepatitis D Therap...

1/23/2026Mabwell Advances CDH17 ADC Program with First U.S. Patient Dosed

1/23/2026Insilicon Secures FDA IND Clearance for Oral NLRP3 Inhibitor ISM8969

1/22/2026Henlius Gains NMPA Green Light for Phase 1b/2 Trial of HLX701

1/22/2026Genmab Halts Development of Three China-Originated Oncology Assets fro...

1/22/2026Daiichi Sankyo Wins New China Approval for Enhertu

1/22/2026AbbVie Secures China Approval for Skyrizi in Ulcerative Colitis

1/22/2026Juncell Unveils Phase I TIL Data for Advanced NSCLC as IPO Push Accele...

1/21/2026China Launches Clinical Trial of First Acne Vaccine Candidate

1/21/2026Roche Advances Oral GLP-1 Program as RO7795081 Cleared for China Clini...

1/21/2026Pfizer Pulls Back on Mesothelin-Targeting ADC Sublicensed from Harbour...

1/21/2026Telix Advances China Strategy as Prostate Cancer Imaging Filing Clears...

1/16/2026Takeda Submits China Marketing Application for Obretone Tablets

1/16/2026Sanofi Gains Approval for Two Innovative Therapies in China

1/14/2026Chinese Scientists Unveil Novel Intratumoral Vaccine

1/14/2026Pfizer Announces Completion of Key China Phase 3 Trial for Migraine Dr...

1/13/2026Abbisko's Pimicotinib Advances Toward U.S. Approval as FDA Accepts NDA

1/13/2026China Weighs Approval of Russian Cancer Vaccine

1/12/2026Eli Lilly Submits Orforglipron NDA in China for GLP-1R Agonist

1/12/2026Henlius Reports Promising Phase 2 Results for PD-L1 ADC HLX43

1/9/2026Hengrui Secures China Approval for Retlirafusp Alfa for Gastric Cancer

1/8/2026BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC

1/8/2026Hansoh Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile

1/8/2026Luye's Ruoxinlin NDA Accepted in China for Anxiety Disorder Treatment

1/8/2026Hengrui Wins China Approval for Retlirafusp Alfa

1/8/2026HUTCHMED Reports Positive Phase III Results for Sovleplenib in China

1/8/2026AskBio Receives FDA Acceptance of IND for AB-1009 Gene Therapy

1/8/2026Curium's IND for 177Lu-PSMA-I&T Accepted for Review in China

Page:1/21 Total number of articles:626: [First][<<] [1] [2] [3] [4] [5] [>>] [End]